Lamar Advertising reported a 6.6% increase in net revenues to $624.5 million and a 14.5% rise in net income to $165 million for Q3 2026, driven by strong demand from national clients, digital platforms, and political advertising. Adjusted EBITDA grew 9.3%, and adjusted funds from operations (AFFO) rose 10.1%, prompting the company to raise its full-year AFFO per diluted share guidance to $8.87-$8.97. The company also reported solid cash flow and free cash flow growth, highlighting operational strength. Lamar's outlook reflects confidence in continued growth fueled by digital expansion and political spending.
Lamar Advertising Company announced a 14.5% rise in net income to $165 million for Q3 2026. For readers following the Media sector, here is Pluang's market snapshot as of Nov 05, 2026 18:11 WIB: out of 57 priced US Media-sector stocks, 35 rose and 19 fell today. Notable movers include NWSA at USD 28.91 with a 1-day change of -5.40%, BILI at USD 14.56 up 4.90%, and FVRR at USD 8.39 down 3.67%. Typical hold times on Pluang range from 15 to 64 days, with varied order activity percentages.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
